Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
MacroGenics, Inc. is a biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of innovative antibody-based cancer therapeutics. Its core platforms include bispecific and multi-specific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors. The company targets solid tumors and hematologic malignancies, leveraging proprietary technologies and strategic collaborations to advance its pipeline and generate revenue through licensing, partnerships, and manufacturing services.
This description was generated via AI from an annual report. Updated about 1 year ago.